Costs of healthcare-associated infections in an Intensive Care Unit

Abstract

Objectives: to evaluate hospitalization costs of patients with and without Healthcare-Associated Infections an Intensive Care Unit. Methods: a retrospective case-control study. Data collection was retrieved from the medical records of Intensive Care Unit of a medium-sized public hospital in Goiás-Brazil. For each case, two controls were selected. Data on socioeconomic, clinical, and hospital costs were collected. To verify associations between variables, Odds Ratio and linear regression were calculated. Results: a total of 21 patients diagnosed with Healthcare-Associated Infections and 42 controls were evaluated. The hospitalization cost for patients with infection was four times higher than for non-infection patients (p-value<0.001). There was an association between infection and higher mortality (p-value <0.001), longer hospital-stay (p-value =0.021), and higher hospital costs (p-value =0.007). Conclusions: hospitalization costs of diagnosed Healthcare-Associated Infections patients are high compared to those who do not have this diagnosis.

Bir yoğun bakım ünitesinde sık görülen enfeksiyonların önlenmesi için bir bakım paketinin etkinlik ve maliyetinin analizi: Yarı deneysel bir öntest-sontest tasarım çalışması

“…In the study of Osme et al (2021) with intensive care patients, it was stated that HCAIs prolong the length of stay in the hospital and place an extra burden on the health system (25). In the literature, examination of the economic dimension of HCAIs in the ICU is very limited, and existing studies have reached similar results to the present study (25,38). It is thought that the decrease in examination and treatment interventions in the present study, which was due to the decrease in infection rates and the shortening of the hospital stay, also caused a decrease in costs.…”

“…In addition, the length of hospital stay is an important criterion used to evaluate the financial burden of HCAIs (37). In the study conducted by Leal and Freitas-Vilela (2021), it was concluded that the hospitalization cost of intensive care patients who developed was four times higher than the patients who did not develop infections, and that there was a relationship between infection and longer hospital stay (38). In the study of Osme et al (2021) with intensive care patients, it was stated that HCAIs prolong the length of stay in the hospital and place an extra burden on the health system (25).…”

Clinical Impact and Risk Factors of Intensive Care Unit-Acquired Nosocomial Infection: A Propensity Score-Matching Study from 2018 to 2020 in a Teaching Hospital in China

“…This finding was not consistent with that of the other studies. 47 , 51 , 52 Another review showed that all SSIs were not similar. Although by definition, all SSIs were costly; however, the principal determinants of the cost of an SSI were geographic locale, the type of surgery performed, and the depth of the infection.…”

Application of ventilator-associated events (VAE) in ventilator-associated pneumonia (VAP) notified in Brazil (IMPACTO MR-PAV): a protocol for a cohort study

“…second most common healthcare-associated infection (HAI), accounting for 27% of all HAIs. [9][10][11] The mortality rate associated with VAP in Brazil is estimated to be around 30%-50%. 12 13 Given the high incidence and mortality rate of VAP, there is a need for reliable surveillance methods to accurately identify and track cases.…”

“…In Brazil, VAP is also a significant public health problem, with a reported incidence ranging from 10 to 57 cases per 1000 ventilator days 8. A study conducted in a tertiary hospital in Brazil found that VAP was the second most common healthcare-associated infection (HAI), accounting for 27% of all HAIs 9–11. The mortality rate associated with VAP in Brazil is estimated to be around 30%–50% 12 13…”